Fratagene Therapeutics

Fratagene Therapeutics is a company that develops research programs aiming to find a therapy for Friedreich ataxia. Its technology platform is focused on ubiquitin-competing molecules (UCM), long-lasting frataxin (LLF), etravirine, interferon gamma (IFNγ), and Src inhibitors.